Hazard ratios for Parkinson's disease associated with dihydropyridine and non-dihydropyridine calcium channel blockers, as compared with beta blockers in hypertension population.

aStratified by baseline disease risk score deciles and adjusted for time varying co-morbidities and medications use (statins, anti-diabetes, anti-platelets, non-steroidal anti-inflammatory drugs, anti-psychotics, ischemic heart disease, heart failure, chronic kidney disease, and chronic obstructive pulmonary disease). eCalculated as quartiles of cumulative defined daily dose (DDD) of the drug class category. ACE, angiotensin converting enzyme; HR, hazard ratio.